N-Nitroso-Pramipexole
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Pramipexole is used to treat Parkinson disease. It may be used alone or in combination with other medicines (eg, levodopa). Pramipexole is a dopamine agonist that works on the nervous system to help treat the symptoms of Parkinson disease. Pramipexole is also used to treat Restless Legs Syndrome (RLS). N-Nitroso-Pramipexole is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso-Pramipexole chemically represented as (S)-N-(2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-N-propylnitrous amide .Synchemia is the leading manufacturing and exporter of N-Nitroso-Pramipexole . We supply N-Nitroso-Pramipexole with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141555 |
| CAS No | NA |
| Mol.F. | C21H23N5O3S |
| Mol.Wt. | 425.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141556 |
| CAS No | NA |
| Mol.F. | C26H27N7O4S2 |
| Mol.Wt. | 565.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141557 |
| CAS No | NA |
| Mol.F. | C16H17N3O4 |
| Mol.Wt. | 315.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141558 |
| CAS No | NA |
| Mol.F. | C16H17N3O3 |
| Mol.Wt. | 299.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141559 |
| CAS No | NA |
| Mol.F. | C17H21N3O2 |
| Mol.Wt. | 299.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141560 |
| CAS No | NA |
| Mol.F. | C17H21N3O2 |
| Mol.Wt. | 299.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141561 |
| CAS No | NA |
| Mol.F. | C21H22N6O4S |
| Mol.Wt. | 454.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141562 |
| CAS No | NA |
| Mol.F. | C16H15N3O5 |
| Mol.Wt. | 329.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141563 |
| CAS No | NA |
| Mol.F. | C6H13N3O3 |
| Mol.Wt. | 175.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141564 |
| CAS No | NA |
| Mol.F. | C21H23N3O6S2 |
| Mol.Wt. | 477.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141565 |
| CAS No | NA |
| Mol.F. | C23H27N3O6S2 |
| Mol.Wt. | 505.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141566 |
| CAS No | NA |
| Mol.F. | C15H12Cl2N2O3 |
| Mol.Wt. | 339.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141567 |
| CAS No | NA |
| Mol.F. | C12H8Cl2N2O |
| Mol.Wt. | 267.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141568 |
| CAS No | NA |
| Mol.F. | C13H8Cl2N2O2 |
| Mol.Wt. | 295.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141569 |
| CAS No | NA |
| Mol.F. | C13H10Cl2N2O2 |
| Mol.Wt. | 297.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141570 |
| CAS No | NA |
| Mol.F. | C14H10BrClN2O3 |
| Mol.Wt. | 369.6 |
| INV STATUS | CUSTOM SYNTHESIS |